< Back to latest news & events

Event

CITMA Lecture – London

April 2019

Event date: 30th April 2019

HGF Senior Trade Mark Attorney Lauren Somers will be discussing one of the less publicised effects of the GDPR: the WHOIS blackout at the upcoming CITMA lunchtime lecture Tuesday 30th April 2019.

How have the recent changes in WHOIS disclosure had an impact on domain name disputes?

Lauren Somers will be discussing one of the less publicised effects of the GDPR: the WHOIS blackout at the very first CITMA lunchtime lecture in London.

In the one hour lecture Lauren considers the practical implications of the lack of registrant data pre-filing UDRP complaints.

She will also discuss different ways to extract data, privacy shields, and the proposed accreditation system that would give representatives access to registrant data.

Attendees

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article